United States Free Fatty Acid Receptor 4 Market Report 2017

January 2018 | 101 pages | ID: U294ACDF5C8EN
QYResearch

Abstracts

In this report, the United States Free Fatty Acid Receptor 4 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Free Fatty Acid Receptor 4 in these regions, from 2012 to 2022 (forecast).

United States Free Fatty Acid Receptor 4 market competition by top manufacturers/players, with Free Fatty Acid Receptor 4 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Advinus Therapeutics Ltd
• AstraZeneca Plc
• CymaBay Therapeutics Inc
• Dompe Farmaceutici SpA
• GlaxoSmithKline Plc
• Merck & Co Inc
• Sancilio & Company Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• CB-001
• GSK-137647A
• SC-410
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Non Alcoholic Fatty Liver Disease
• Type 2 Diabets
• Metabolic Disorders
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Free Fatty Acid Receptor 4 Market Report 2017

1 FREE FATTY ACID RECEPTOR 4 OVERVIEW

1.1 Product Overview and Scope of Free Fatty Acid Receptor
1.2 Classification of Free Fatty Acid Receptor 4 by Product Category
  1.2.1 United States Free Fatty Acid Receptor 4 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Free Fatty Acid Receptor 4 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 CB-001
  1.2.4 GSK-137647A
  1.2.5 SC-410
  1.2.6 Others
1.3 United States Free Fatty Acid Receptor 4 Market by Application/End Users
  1.3.1 United States Free Fatty Acid Receptor 4 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Non Alcoholic Fatty Liver Disease
  1.3.3 Type 2 Diabets
  1.3.4 Metabolic Disorders
  1.3.5 Others
1.4 United States Free Fatty Acid Receptor 4 Market by Region
  1.4.1 United States Free Fatty Acid Receptor 4 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Free Fatty Acid Receptor 4 Status and Prospect (2012-2022)
  1.4.3 Southwest Free Fatty Acid Receptor 4 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Free Fatty Acid Receptor 4 Status and Prospect (2012-2022)
  1.4.5 New England Free Fatty Acid Receptor 4 Status and Prospect (2012-2022)
  1.4.6 The South Free Fatty Acid Receptor 4 Status and Prospect (2012-2022)
  1.4.7 The Midwest Free Fatty Acid Receptor 4 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Free Fatty Acid Receptor 4 (2012-2022)
  1.5.1 United States Free Fatty Acid Receptor 4 Sales and Growth Rate (2012-2022)
  1.5.2 United States Free Fatty Acid Receptor 4 Revenue and Growth Rate (2012-2022)

2 UNITED STATES FREE FATTY ACID RECEPTOR 4 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Free Fatty Acid Receptor 4 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Free Fatty Acid Receptor 4 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Free Fatty Acid Receptor 4 Average Price by Players/Suppliers (2012-2017)
2.4 United States Free Fatty Acid Receptor 4 Market Competitive Situation and Trends
  2.4.1 United States Free Fatty Acid Receptor 4 Market Concentration Rate
  2.4.2 United States Free Fatty Acid Receptor 4 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Free Fatty Acid Receptor 4 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES FREE FATTY ACID RECEPTOR 4 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Free Fatty Acid Receptor 4 Sales and Market Share by Region (2012-2017)
3.2 United States Free Fatty Acid Receptor 4 Revenue and Market Share by Region (2012-2017)
3.3 United States Free Fatty Acid Receptor 4 Price by Region (2012-2017)

4 UNITED STATES FREE FATTY ACID RECEPTOR 4 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Free Fatty Acid Receptor 4 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Free Fatty Acid Receptor 4 Revenue and Market Share by Type (2012-2017)
4.3 United States Free Fatty Acid Receptor 4 Price by Type (2012-2017)
4.4 United States Free Fatty Acid Receptor 4 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES FREE FATTY ACID RECEPTOR 4 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Free Fatty Acid Receptor 4 Sales and Market Share by Application (2012-2017)
5.2 United States Free Fatty Acid Receptor 4 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES FREE FATTY ACID RECEPTOR 4 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Advinus Therapeutics Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Free Fatty Acid Receptor 4 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca Plc
  6.2.2 Free Fatty Acid Receptor 4 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Plc Free Fatty Acid Receptor 4 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CymaBay Therapeutics Inc
  6.3.2 Free Fatty Acid Receptor 4 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dompe Farmaceutici SpA
  6.4.2 Free Fatty Acid Receptor 4 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline Plc
  6.5.2 Free Fatty Acid Receptor 4 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck & Co Inc
  6.6.2 Free Fatty Acid Receptor 4 Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck & Co Inc Free Fatty Acid Receptor 4 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sancilio & Company Inc
  6.7.2 Free Fatty Acid Receptor 4 Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 FREE FATTY ACID RECEPTOR 4 MANUFACTURING COST ANALYSIS

7.1 Free Fatty Acid Receptor 4 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Free Fatty Acid Receptor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Free Fatty Acid Receptor 4 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Free Fatty Acid Receptor 4 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES FREE FATTY ACID RECEPTOR 4 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Free Fatty Acid Receptor 4 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Free Fatty Acid Receptor 4 Sales Volume Forecast by Type (2017-2022)
11.3 United States Free Fatty Acid Receptor 4 Sales Volume Forecast by Application (2017-2022)
11.4 United States Free Fatty Acid Receptor 4 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Free Fatty Acid Receptor
Figure United States Free Fatty Acid Receptor 4 Market Size (K Pcs) by Type (2012-2022)
Figure United States Free Fatty Acid Receptor 4 Sales Volume Market Share by Type (Product Category) in 2016
Figure CB-001 Product Picture
Figure GSK-137647A Product Picture
Figure SC-410 Product Picture
Figure Others Product Picture
Figure United States Free Fatty Acid Receptor 4 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Free Fatty Acid Receptor 4 by Application in 2016
Figure Non Alcoholic Fatty Liver Disease Examples
Table Key Downstream Customer in Non Alcoholic Fatty Liver Disease
Figure Type 2 Diabets Examples
Table Key Downstream Customer in Type 2 Diabets
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Free Fatty Acid Receptor 4 Market Size (Million USD) by Region (2012-2022)
Figure The West Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Free Fatty Acid Receptor 4 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Free Fatty Acid Receptor 4 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Free Fatty Acid Receptor 4 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Free Fatty Acid Receptor 4 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Free Fatty Acid Receptor 4 Sales Share by Players/Suppliers
Figure 2017 United States Free Fatty Acid Receptor 4 Sales Share by Players/Suppliers
Figure United States Free Fatty Acid Receptor 4 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Free Fatty Acid Receptor 4 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Free Fatty Acid Receptor 4 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Free Fatty Acid Receptor 4 Revenue Share by Players/Suppliers
Figure 2017 United States Free Fatty Acid Receptor 4 Revenue Share by Players/Suppliers
Table United States Market Free Fatty Acid Receptor 4 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Free Fatty Acid Receptor 4 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Free Fatty Acid Receptor 4 Market Share of Top 3 Players/Suppliers
Figure United States Free Fatty Acid Receptor 4 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Free Fatty Acid Receptor 4 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Free Fatty Acid Receptor 4 Product Category
Table United States Free Fatty Acid Receptor 4 Sales (K Pcs) by Region (2012-2017)
Table United States Free Fatty Acid Receptor 4 Sales Share by Region (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Share by Region (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Market Share by Region in 2016
Table United States Free Fatty Acid Receptor 4 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Free Fatty Acid Receptor 4 Revenue Share by Region (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Revenue Market Share by Region (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Revenue Market Share by Region in 2016
Table United States Free Fatty Acid Receptor 4 Price (USD/Pcs) by Region (2012-2017)
Table United States Free Fatty Acid Receptor 4 Sales (K Pcs) by Type (2012-2017)
Table United States Free Fatty Acid Receptor 4 Sales Share by Type (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Share by Type (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Market Share by Type in 2016
Table United States Free Fatty Acid Receptor 4 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Free Fatty Acid Receptor 4 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Free Fatty Acid Receptor 4 by Type (2012-2017)
Figure Revenue Market Share of Free Fatty Acid Receptor 4 by Type in 2016
Table United States Free Fatty Acid Receptor 4 Price (USD/Pcs) by Types (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Growth Rate by Type (2012-2017)
Table United States Free Fatty Acid Receptor 4 Sales (K Pcs) by Application (2012-2017)
Table United States Free Fatty Acid Receptor 4 Sales Market Share by Application (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Market Share by Application (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Market Share by Application in 2016
Table United States Free Fatty Acid Receptor 4 Sales Growth Rate by Application (2012-2017)
Figure United States Free Fatty Acid Receptor 4 Sales Growth Rate by Application (2012-2017)
Table Advinus Therapeutics Ltd Basic Information List
Table Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales Growth Rate (2012-2017)
Figure Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Sales Market Share in United States (2012-2017)
Figure Advinus Therapeutics Ltd Free Fatty Acid Receptor 4 Revenue Market Share in United States (2012-2017)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc Free Fatty Acid Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Free Fatty Acid Receptor 4 Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc Free Fatty Acid Receptor 4 Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc Free Fatty Acid Receptor 4 Revenue Market Share in United States (2012-2017)
Table CymaBay Therapeutics Inc Basic Information List
Table CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales Growth Rate (2012-2017)
Figure CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Sales Market Share in United States (2012-2017)
Figure CymaBay Therapeutics Inc Free Fatty Acid Receptor 4 Revenue Market Share in United States (2012-2017)
Table Dompe Farmaceutici SpA Basic Information List
Table Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales Growth Rate (2012-2017)
Figure Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Sales Market Share in United States (2012-2017)
Figure Dompe Farmaceutici SpA Free Fatty Acid Receptor 4 Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Free Fatty Acid Receptor 4 Revenue Market Share in United States (2012-2017)
Table Merck & Co Inc Basic Information List
Table Merck & Co Inc Free Fatty Acid Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co Inc Free Fatty Acid Receptor 4 Sales Growth Rate (2012-2017)
Figure Merck & Co Inc Free Fatty Acid Receptor 4 Sales Market Share in United States (2012-2017)
Figure Merck & Co Inc Free Fatty Acid Receptor 4 Revenue Market Share in United States (2012-2017)
Table Sancilio & Company Inc Basic Information List
Table Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales Growth Rate (2012-2017)
Figure Sancilio & Company Inc Free Fatty Acid Receptor 4 Sales Market Share in United States (2012-2017)
Figure Sancilio & Company Inc Free Fatty Acid Receptor 4 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Free Fatty Acid Receptor
Figure Manufacturing Process Analysis of Free Fatty Acid Receptor
Figure Free Fatty Acid Receptor 4 Industrial Chain Analysis
Table Raw Materials Sources of Free Fatty Acid Receptor 4 Major Players/Suppliers in 2016
Table Major Buyers of Free Fatty Acid Receptor
Table Distributors/Traders List
Figure United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Free Fatty Acid Receptor 4 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Free Fatty Acid Receptor 4 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Free Fatty Acid Receptor 4 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources